Axon Enterprise (NASDAQ:AXON) Given Market Outperform Rating at Citizens Jmp

Citizens Jmp reissued their market outperform rating on shares of Axon Enterprise (NASDAQ:AXON) in a research report released on Monday,Benzinga reports. The brokerage currently has a $825.00 price target on the biotechnology company’s stock.

Several other equities analysts also recently commented on AXON. Morgan Stanley reaffirmed an “overweight” rating on shares of Axon Enterprise in a research report on Wednesday, April 8th. Robert W. Baird set a $800.00 price objective on Axon Enterprise in a research report on Wednesday, February 25th. Weiss Ratings downgraded Axon Enterprise from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday. Northcoast Research raised Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price target on the stock in a research report on Tuesday, January 6th. Finally, The Goldman Sachs Group dropped their price target on Axon Enterprise from $720.00 to $625.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Sixteen investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $755.88.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $359.63 on Monday. The stock’s fifty day moving average is $462.40 and its two-hundred day moving average is $561.94. The company has a market capitalization of $28.91 billion, a PE ratio of 236.60, a price-to-earnings-growth ratio of 7.38 and a beta of 1.61. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. Axon Enterprise has a 52 week low of $339.01 and a 52 week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating the consensus estimate of $1.60 by $0.55. The company had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.Axon Enterprise’s quarterly revenue was up 38.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.08 EPS. As a group, analysts expect that Axon Enterprise will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, Director Jeri Williams sold 157 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total transaction of $76,930.00. Following the transaction, the director owned 1,159 shares of the company’s stock, valued at approximately $567,910. This represents a 11.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total value of $5,002,400.00. Following the sale, the chief executive officer directly owned 3,090,997 shares in the company, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 13,855 shares of company stock worth $7,109,828. Insiders own 4.40% of the company’s stock.

Institutional Investors Weigh In On Axon Enterprise

Institutional investors have recently added to or reduced their stakes in the stock. Stone House Investment Management LLC bought a new stake in Axon Enterprise during the third quarter valued at about $29,000. New Millennium Group LLC bought a new stake in Axon Enterprise during the third quarter valued at about $29,000. Darwin Wealth Management LLC bought a new stake in Axon Enterprise during the second quarter valued at about $37,000. Root Financial Partners LLC bought a new stake in Axon Enterprise during the third quarter valued at about $34,000. Finally, Creative Financial Designs Inc. ADV bought a new stake in Axon Enterprise during the fourth quarter valued at about $28,000. Institutional investors own 79.08% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.